Concepedia

Scottsdale Research Institute (United States)

SR

560

Publications

18.3K

Citations

32

Authors

Phoenix

United States

Other names

SRI

Scottsdale Research Institute (United States) is a company institution in Phoenix, United States known for medicine, oncology, and pathology.

HomepageROR

Top concepts

Publications

560

Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449

Charles M. Rudin, Christine L. Hann, John Laterra et al. · New England Journal of Medicine · 2009 · 1K citations · Full text

, , +12

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors

Muhammad S. Beg, Andrew Brenner, Jasgit C. Sachdev et al. · Investigational New Drugs · 2016 · 855 citations · Full text

, , +8

Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

David S. Hong, Yoon‐Koo Kang, Mitesh J. Borad et al. · British Journal of Cancer · 2020 · 850 citations · Full text

Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline <i>BRCA1/2</i> Mutations and Selected Sporadic Cancers

Johann S. de Bono, Ramesh K. Ramanathan, Lida A. Mina et al. · Cancer Discovery · 2017 · 376 citations · Full text

Classification of the Acanthocephala

Omar M. Amin · Folia Parasitologica · 2013 · 345 citations · Full text

, , +21

Rows per page

1–5 of 560

Authors

32

PublicationsCitationsH-Index
AR
Ann Rosalind Jones

Scottsdale Research Institute (United States)

60

1K

14

TW
Tom Wolvos

Scottsdale Research Institute (United States)

11

348

7

JC
J. Charles Casebeer

Scottsdale Research Institute (United States)

16

110

7

GV
Gabriel Varga

Scottsdale Research Institute (United States)

59

367

5

DL
David Lawrence Greene

Scottsdale Research Institute (United States)

10

120

5

Rows per page

1–5 of 32